The first one shows that in AAT+/+ transgenic mice that express human AAT in lungs, the mortality of Pseudomonas aeruginosa-induced pneumonia was reduced of 90% compared to non-transgenic control animals. The gene discussed is SERPINA1; the disease is pneumonia.